{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:54:54Z","timestamp":1788825294323,"version":"build-2803163510"},"reference-count":92,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Immunoassay-based urine drug screens are widely employed in clinical toxicology due to their speed, low cost, and ease of automation. However, these assays are inherently limited by antibody cross-reactivity, which can result in false-positive findings and incorrect interpretations with major implications for patient care, employment, and legal outcomes. This review updates prior literature by analyzing reported false-positive interferences published between 2013 and 2024 across commonly screened drug classes, including opioids, amphetamines, benzodiazepines, cannabinoids, barbiturates, phencyclidine (PCP), cocaine, ethanol, and ethyl glucuronide. A total of 61 studies met inclusion criteria from 569 unique publications retrieved via PubMed. Each report was categorized by level of evidence, ranging from single case reports to controlled spiking experiments. Despite advances in antibody specificity, immunoassay drug screens remain presumptive and require confirmation by orthogonal techniques such as gas or liquid chromatography coupled with mass spectrometry (GC\u2013MS or LC\u2013MS\/MS). This review provides updated reference data on known interferents, emphasizes the need for laboratorian\u2013clinician communication, and supports continued education on assay limitations. Reliable interpretation of presumptive immunoassay drug screen results remains essential to prevent inappropriate clinical care decisions.<\/jats:p>","DOI":"10.1093\/jat\/bkag007","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T12:47:51Z","timestamp":1769777271000},"source":"Crossref","is-referenced-by-count":2,"title":["False positive urine drug screens"],"prefix":"10.1093","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4590-9077","authenticated-orcid":false,"given":"Alec","family":"Saitman","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Oregon Health & Science University School of Medicine , Portland, OR 97239,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L","family":"Fitzgerald","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of California San Diego , La Jolla, CA 92093,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Lund","sequence":"additional","affiliation":[{"name":"Department of Pathology and Area Laboratory Sciences, Landstuhl Regional Medical Center , Landstuhl, 66849,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4767-7639","authenticated-orcid":false,"given":"Raymond T","family":"Suhandynata","sequence":"additional","affiliation":[{"name":"Department of Pathology, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego , La Jolla, CA 92093,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlen","family":"Menlyadiev","sequence":"additional","affiliation":[{"name":"Diagnostic Medicine Institute, Geisinger Health System , Danville, PA 17822,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"key":"2026052302060992000_bkag007-B1","author":"Datta","year":"2019"},{"key":"2026052302060992000_bkag007-B2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/jat\/bku075","article-title":"False-positive interferences of common urine drug screen immunoassays: a review","volume":"38","author":"Saitman","year":"2014","journal-title":"J Anal Toxicol"},{"key":"2026052302060992000_bkag007-B3","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.mayocp.2016.12.007","article-title":"Clinical interpretation of urine drug tests: what clinicians need to know about urine drug screens","volume":"92","author":"Moeller","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"2026052302060992000_bkag007-B4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.5055\/jom.2007.0044","article-title":"Urine drug test interpretation: what do physicians know?","volume":"3","author":"Reisfield","year":"2007","journal-title":"J Opioid Manag"},{"key":"2026052302060992000_bkag007-B5","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/pme.12265","article-title":"The clinical impact of a false-positive urine cocaine screening result on a patient\u2019s pain management","volume":"16","author":"Kim","year":"2015","journal-title":"Pain Med"},{"key":"2026052302060992000_bkag007-B6","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/jat\/bkz019","article-title":"False-positive serum cocaine screening results in patients undergoing evaluation for renal transplant","volume":"43","author":"Snozek","year":"2019","journal-title":"J Anal Toxicol"},{"key":"2026052302060992000_bkag007-B7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5858\/arpa.2018-0562-CP","article-title":"Interpretation and utility of drug of abuse screening immunoassays: insights from laboratory drug testing proficiency surveys","volume":"144","author":"Krasowski","year":"2020","journal-title":"Arch Pathol Lab Med"},{"key":"2026052302060992000_bkag007-B8","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/jalm\/jfaf069","article-title":"Clinical drug testing supporting patients with substance use disorder: a review","volume":"10","author":"Saitman","year":"2025","journal-title":"J Appl Lab Med"},{"key":"2026052302060992000_bkag007-B9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/10408363.2019.1585415","article-title":"Mass spectrometry in emergency toxicology: current state and future applications","volume":"56","author":"Van Wijk","year":"2019","journal-title":"Crit Rev Clin Lab Sci"},{"key":"2026052302060992000_bkag007-B10","first-page":"272","article-title":"Mass spectrometry applications for toxicology","volume":"27","author":"Mbughuni","year":"2016","journal-title":"EJIFCC"},{"key":"2026052302060992000_bkag007-B11","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3390\/ph18071055","article-title":"Pharmacology and toxicology of opioids-recent advances and new perspectives","volume":"18","author":"Barbosa","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"key":"2026052302060992000_bkag007-B12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2147\/SAR.S88935","article-title":"Cross-reactivity of the CEDIA buprenorphine assay in drugs-of-abuse screening: influence of dose and metabolites of opioids","volume":"6","author":"Berg","year":"2015","journal-title":"Subst Abuse Rehabil"},{"key":"2026052302060992000_bkag007-B13","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1093\/jalm\/jfac065","article-title":"An opioid hiding in plain sight: loperamide-induced false-positive fentanyl and buprenorphine immunoassay results","volume":"7","author":"Geno","year":"2022","journal-title":"J Appl Lab Med"},{"key":"2026052302060992000_bkag007-B14","doi-asserted-by":"crossref","first-page":"110944","DOI":"10.1016\/j.intimp.2023.110944","article-title":"Loperamide, a peripheral Mu-Opioid receptor agonist, attenuates chemotherapy-induced neuropathic pain in rats","volume":"124","author":"Gadepalli","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"2026052302060992000_bkag007-B15","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.clinbiochem.2019.04.009","article-title":"Commonly used fluoroquinolones cross-react with urine drug screens for opiates, buprenorphine, and amphetamines","volume":"68","author":"Colby","year":"2019","journal-title":"Clin Biochem"},{"key":"2026052302060992000_bkag007-B16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/jat\/bkt016","article-title":"False-positive buprenorphine by CEDIA in patients prescribed amisulpride or sulpiride","volume":"37","author":"Birch","year":"2013","journal-title":"J Anal Toxicol"},{"key":"2026052302060992000_bkag007-B17","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1373\/clinchem.2019.305409","article-title":"Discovering cross-reactivity in urine drug screening immunoassays through large-scale analysis of electronic health records","volume":"65","author":"Hughey","year":"2019","journal-title":"Clin Chem"},{"key":"2026052302060992000_bkag007-B18","first-page":"290","article-title":"False positives in urine methadone screening secondary to tapentadol","volume":"32","author":"Gomila Muniz","year":"2020","journal-title":"Emergencias"},{"key":"2026052302060992000_bkag007-B19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2019.08.026","article-title":"Vortioxetine use may cause false positive immunoassay results for urine methadone","volume":"499","author":"Uljon","year":"2019","journal-title":"Clin Chim Acta"},{"key":"2026052302060992000_bkag007-B20","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/1078390318792601","article-title":"Three recent cases of likely methadone cross-reactivity with vortioxetine","volume":"25","author":"Kieran","year":"2019","journal-title":"J Am Psychiatr Nurses Assoc"},{"key":"2026052302060992000_bkag007-B21","doi-asserted-by":"crossref","first-page":"e00334","DOI":"10.1016\/j.plabm.2023.e00334","article-title":"A case of false positive opiate immunoassay results from rifampin (rifampicin) treatment","volume":"37","author":"Lam","year":"2023","journal-title":"Pract Lab Med."},{"key":"2026052302060992000_bkag007-B22","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1080\/15563650.2022.2071285","article-title":"False positive opiate \u00adimmunoassay caused by diphenhydramine","volume":"60","author":"Temple","year":"2022","journal-title":"Clin Toxicol (Phila)"},{"key":"2026052302060992000_bkag007-B23","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cca.2015.07.015","article-title":"High concentrations of dextromethorphan result in false-positive in opiate immunoassay test","volume":"448","author":"Finn","year":"2015","journal-title":"Clin Chim Acta"},{"key":"2026052302060992000_bkag007-B24","first-page":"4370648","article-title":"False positive tramadol urine testing in patients taking fexofenadine: a tale of two consecutive cases","volume":"2023","author":"Yousuf","year":"2023","journal-title":"Case Rep Psychiatry"},{"key":"2026052302060992000_bkag007-B25","first-page":"23","article-title":"Propoxyphene withdrawn from the market","volume":"111","author":"Aschenbrenner","year":"2011","journal-title":"Am J Nurs"},{"key":"2026052302060992000_bkag007-B26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/jat\/bkaa179","article-title":"Analysis of electronic health records reveals medication-related interference on point-of-care urine drug screening assays","volume":"46","author":"Ayala-Lopez","year":"2022","journal-title":"J Anal Toxicol"},{"key":"2026052302060992000_bkag007-B27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neuropharm.2017.10.016","article-title":"Fentanyl, fentanyl \u00adanalogs and novel synthetic opioids: A comprehensive review","volume":"134","author":"Armenian","year":"2018","journal-title":"Neuropharmacology"},{"key":"2026052302060992000_bkag007-B28","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/jat\/bku103","article-title":"Cross-reactivity of acetylfentanyl and risperidone with a fentanyl immunoassay","volume":"38","author":"Wang","year":"2014","journal-title":"J Anal Toxicol"},{"key":"2026052302060992000_bkag007-B29","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.japh.2022.05.011","article-title":"A false positive fentanyl result on urine drug screen in a patient treated with ziprasidone","volume":"62","author":"Waters","year":"2022","journal-title":"J Am Pharm Assoc (2003)"},{"key":"2026052302060992000_bkag007-B30","doi-asserted-by":"crossref","first-page":"e417","DOI":"10.1097\/ADM.0000000000001010","article-title":"False-positive fentanyl urine detection after initiation of labetalol treatment for hypertension in pregnancy: a case report","volume":"16","author":"Wanar","year":"2022","journal-title":"J Addict Med"},{"key":"2026052302060992000_bkag007-B31","doi-asserted-by":"crossref","first-page":"111287","DOI":"10.1016\/j.drugalcdep.2024.111287","article-title":"Understand the FDA-cleared fentanyl testing: a clinical evaluation of the SEFRIA fentanyl immunoassay","volume":"259","author":"Wang","year":"2024","journal-title":"Drug Alcohol Depend"},{"key":"2026052302060992000_bkag007-B32","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/jat\/bkab033","article-title":"ELISA screens for fentanyl in urine are susceptible to false-positives in high concentration methamphetamine samples","volume":"46","author":"Abbott","year":"2022","journal-title":"J Anal Toxicol"},{"key":"2026052302060992000_bkag007-B33","first-page":"2180","article-title":"The therapeutic potential of amphetamine-like psychostimulants","volume":"13","author":"Pires","year":"2023","journal-title":"Life (Basel)"},{"key":"2026052302060992000_bkag007-B34","first-page":"37","article-title":"One hundred false-positive amphetamine specimens characterized by liquid chromatography time-of-flight mass spectrometry","volume":"40","author":"Marin","year":"2016","journal-title":"J Anal Toxicol"},{"key":"2026052302060992000_bkag007-B35","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/jat\/bkac089","article-title":"False-positive amphetamines in urine drug screens: a 6-year review","volume":"47","author":"Pope","year":"2023","journal-title":"J Anal Toxicol"},{"key":"2026052302060992000_bkag007-B36","first-page":"211","article-title":"Kavain interference with amphetamine immunoassay","author":"Madhavaram","year":"2020","journal-title":"J Anal Toxicol"},{"key":"2026052302060992000_bkag007-B37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.clinbiochem.2018.05.013","article-title":"False-positive amphetamine results on several drug screening platforms due to mexiletine","volume":"58","author":"Snozek","year":"2018","journal-title":"Clin Biochem"},{"key":"2026052302060992000_bkag007-B38","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.7205\/MILMED-D-15-00442","article-title":"A cross-reactivity of fenofibric acid with MDMA DRI assay","volume":"181","author":"Bugier","year":"2016","journal-title":"Mil Med"},{"key":"2026052302060992000_bkag007-B39","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/jat\/bkv074","article-title":"Fenofibric acid can cause false-positive urine methylenedioxymethamphetamine immunoassay results","volume":"39","author":"Quesada","year":"2015","journal-title":"J Anal Toxicol"},{"key":"2026052302060992000_bkag007-B40","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/jat\/bkz051","article-title":"False positive amphetamines and 3,4-methylenedioxymethamphetamine immunoassays in the presence of metoprolol-two cases reported in clinical toxicology","volume":"44","author":"Leclercq","year":"2020","journal-title":"J Anal Toxicol"},{"key":"2026052302060992000_bkag007-B41","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/FTD.0000000000000382","article-title":"Cross-reactivity of chloroquine and hydroxychloroquine with DRI amphetamine immunoassay","volume":"39","author":"Gomila","year":"2017","journal-title":"Ther Drug Monit"},{"key":"2026052302060992000_bkag007-B42","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/jat\/12.5.255","article-title":"Resolution of methamphetamine stereoisomers in urine drug testing: \u00adurinary excretion of R(-)-methamphetamine following use of nasal inhalers","volume":"12","author":"Fitzgerald","year":"1988","journal-title":"J Anal Toxicol"},{"key":"2026052302060992000_bkag007-B43","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/jat\/bku077","article-title":"Methamphetamine and amphetamine isomer concentrations in human urine \u00adfollowing controlled Vicks VapoInhaler administration","volume":"38","author":"Smith","year":"2014","journal-title":"J Anal Toxicol"},{"key":"2026052302060992000_bkag007-B44","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.sleep.2023.08.031","article-title":"False positive urine \u00adamphetamine immunoassay due to solriamfetol","volume":"110","author":"Kumar","year":"2023","journal-title":"Sleep Med"},{"key":"2026052302060992000_bkag007-B45","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1080\/15563650.2020.1834114","article-title":"Tetracaine from urethral ointment causes false positive amphetamine results by immunoassay","volume":"59","author":"Wijngaard","year":"2021","journal-title":"Clin Toxicol (Phila)"},{"key":"2026052302060992000_bkag007-B46","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cca.2014.09.012","article-title":"Ranitidine interference with standard amphetamine immunoassay","volume":"438","author":"Liu","year":"2015","journal-title":"Clin Chim Acta"},{"key":"2026052302060992000_bkag007-B47","first-page":"381261","article-title":"Amphetamine positive urine toxicology screen secondary to atomoxetine","volume":"2013","author":"Fenderson","year":"2013","journal-title":"Case Rep Psychiatry"},{"key":"2026052302060992000_bkag007-B48","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1111\/bcp.14624","article-title":"False-positive urine screen test for MDMA in a patient exposed to mebeverine","volume":"87","author":"Bedussi","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"2026052302060992000_bkag007-B49","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0196-0644(81)80047-9","article-title":"Acute phencyclidine intoxication: incidence of clinical findings in 1,000 cases","volume":"10","author":"McCarron","year":"1981","journal-title":"Ann Emerg Med"},{"key":"2026052302060992000_bkag007-B50","first-page":"258","article-title":"Positive predictive value of PCP immunoassay at UC San Diego Health","volume":"41","author":"Metushi","year":"2017","journal-title":"J Anal Toxicol"},{"key":"2026052302060992000_bkag007-B51","first-page":"6666197","article-title":"False-positive phencyclidine (PCP) result on 11-panel urine drug screen (UDS) in a 17-year-old adolescent with long-term venlafaxine use","volume":"2023","author":"Kim","year":"2023","journal-title":"Case Rep Psychiatry"},{"key":"2026052302060992000_bkag007-B52","doi-asserted-by":"crossref","first-page":"234e5","DOI":"10.1016\/j.ajem.2022.08.010","article-title":"Case report of a phencyclidine false positive due to lamotrigine use with confirmatory testing","volume":"61","author":"Cole","year":"2022","journal-title":"Am J Emerg Med"},{"key":"2026052302060992000_bkag007-B53","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1192\/pb.39.1.50","article-title":"False positive phencyclidine result on urine drug testing: a little known cause","volume":"39","author":"Landy","year":"2015","journal-title":"BJPsych Bull"},{"key":"2026052302060992000_bkag007-B54","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1080\/15563650.2018.1483026","article-title":"False-positive phencyclidine immunoassay results caused by metronidazole","volume":"56","author":"Fernandez","year":"2018","journal-title":"Clin Toxicol (Phila)"},{"key":"2026052302060992000_bkag007-B55","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3109\/15563650.2013.801982","article-title":"How often do false-positive phencyclidine urine screens occur with use of common medications?","volume":"51","author":"Rengarajan","year":"2013","journal-title":"Clin Toxicol (Phila)"},{"key":"2026052302060992000_bkag007-B56","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ajem.2012.05.028","article-title":"Nonfatal tramadol overdose may cause false-positive phencyclidine on Emit-II assay","volume":"31","author":"King","year":"2013","journal-title":"Am J Emerg Med"},{"key":"2026052302060992000_bkag007-B57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bcr-2017-222106","article-title":"False-positive phencyclidine (PCP) on urine drug screen attributed to desvenlafaxine (Pristiq) use","volume":"2017","author":"Farley","year":"2017","journal-title":"BMJ Case Rep"},{"key":"2026052302060992000_bkag007-B58","first-page":"17","article-title":"Lamotrigine cross-reactivity with phencyclidine in rapid urine toxicology in a research study","volume":"20","author":"McCain","year":"2018","journal-title":"Prim Care Companion CNS Disord"},{"key":"2026052302060992000_bkag007-B59","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jen.2019.01.015","article-title":"Phencyclidine false positive result induced by LamoTRIgine on the PROFILE-V MEDTOXScan drugs of abuse test system","volume":"45","author":"Murphy","year":"2019","journal-title":"J Emerg Nurs"},{"key":"2026052302060992000_bkag007-B60","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s13181-019-00720-3","article-title":"Does lidocaine cause false positive results on cocaine urine drug screen?","volume":"15","author":"Kim","year":"2019","journal-title":"J Med Toxicol"},{"key":"2026052302060992000_bkag007-B61","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.clinbiochem.2021.04.003","article-title":"The analytical performance of six urine drug screens on cobas 6000 and ARCHITECT i2000 compared to LC-MS\/MS gold standard","volume":"93","author":"Abou El Hassan","year":"2021","journal-title":"Clin Biochem"},{"key":"2026052302060992000_bkag007-B62","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3390\/neurolint13040059","article-title":"Benzodiazepines: uses, dangers, and clinical considerations","volume":"13","author":"Edinoff","year":"2021","journal-title":"Neurol Int"},{"key":"2026052302060992000_bkag007-B63","doi-asserted-by":"crossref","first-page":"e283","DOI":"10.1097\/PEC.0000000000002434","article-title":"False-positive urine drug screen for benzodiazepines in a child taking fluoxetine","volume":"37","author":"Callaghan","year":"2021","journal-title":"Pediatr Emerg Care"},{"key":"2026052302060992000_bkag007-B64","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.healun.2018.09.014","article-title":"Pirfenidone causes false-positive urine benzodiazepine results: Implications for patients with pulmonary fibrosis","volume":"37","author":"Pope","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"2026052302060992000_bkag007-B65","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1515\/cclm-2017-0441","article-title":"Interference between ethosuximide and barbiturates in an immunochromatographic method","volume":"56","author":"San-Jose","year":"2018","journal-title":"Clin Chem Lab Med"},{"key":"2026052302060992000_bkag007-B66","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.2174\/092986710790980005","article-title":"Endocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown","volume":"17","author":"Reggio","year":"2010","journal-title":"Curr Med Chem"},{"key":"2026052302060992000_bkag007-B67","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1152\/physrev.00019.2008","article-title":"Endocannabinoid-mediated control of synaptic transmission","volume":"89","author":"Kano","year":"2009","journal-title":"Physiol Rev"},{"key":"2026052302060992000_bkag007-B68","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s13181-019-00753-8","article-title":"ACMT position statement: interpretation of urine for tetrahydrocannabinol metabolites","volume":"16","author":"Connors","year":"2020","journal-title":"J Med Toxicol"},{"key":"2026052302060992000_bkag007-B69","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/jat\/bkad061","article-title":"The preanalytical stability of emerging cannabinoid analogs (delta-8 THC and its metabolites, delta-10 THC and carboxy-HHC) in urine","volume":"47","author":"Pokhai","year":"2023","journal-title":"J Anal Toxicol"},{"key":"2026052302060992000_bkag007-B70","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/dta.3190","article-title":"Analytical and medico-legal problems linked to the presence of delta-8-tetrahydrocannabinol (delta-8-THC): results from urine drug testing in Sweden","volume":"14","author":"Helander","year":"2022","journal-title":"Drug Test Anal"},{"key":"2026052302060992000_bkag007-B71","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/jat\/bkx047","article-title":"Cross-reactivity of pantoprazole with three commercial cannabinoids immunoassays in urine","volume":"41","author":"Gomila","year":"2017","journal-title":"J Anal Toxicol"},{"key":"2026052302060992000_bkag007-B72","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1080\/15563650.2019.1662917","article-title":"An assessment of urine THC immunoassay in healthy volunteers receiving an oral proton-pump inhibitor","volume":"58","author":"Vohra","year":"2020","journal-title":"Clin Toxicol (Phila)"},{"key":"2026052302060992000_bkag007-B73","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/clinchem\/hvac004","article-title":"Biomarkers and clinical laboratory detection of acute and chronic ethanol use","volume":"68","author":"Tawiah","year":"2022","journal-title":"Clin Chem"},{"key":"2026052302060992000_bkag007-B74","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1093\/jat\/bkaa188","article-title":"False-positive ethanol level in urine and plasma samples of a resuscitated infant","volume":"46","author":"Lefr\u00e8re","year":"2022","journal-title":"J Anal Toxicol"},{"key":"2026052302060992000_bkag007-B75","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.forsciint.2017.10.021","article-title":"Lessons learned from a case of tert-butyl glucuronide excretion in urine - \"New\" psychoactive alcohols knocking on the back door?","volume":"281","author":"Arndt","year":"2017","journal-title":"Forensic Sci Int"},{"key":"2026052302060992000_bkag007-B76","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.forsciint.2016.05.027","article-title":"Excessive urinary \u00adexcretion of isopropyl glucuronide after isopropanol abuse","volume":"266","author":"Arndt","year":"2016","journal-title":"Forensic Sci Int"},{"key":"2026052302060992000_bkag007-B77","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.forsciint.2014.05.015","article-title":"Cross-reaction of propyl and butyl alcohol glucuronides with an ethyl glucuronide enzyme immunoassay","volume":"241","author":"Arndt","year":"2014","journal-title":"Forensic Sci Int"},{"key":"2026052302060992000_bkag007-B78","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/jat\/bkad042","article-title":"\u03948-THC-COOH cross-reactivity with cannabinoid immunoassay kits and interference in chromatographic testing methods","volume":"47","author":"Mullen","year":"2023","journal-title":"J Anal Toxicol"},{"key":"2026052302060992000_bkag007-B79","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/jat\/bkae091","article-title":"LC-MS-MS confirmation of 11-nor-9-carboxy-tetrahydrocannabinol (Delta8, Delta9, Delta10) and hexahydrocannabinol metabolites in authentic urine specimens","volume":"49","author":"Patton","year":"2025","journal-title":"J Anal Toxicol"},{"key":"2026052302060992000_bkag007-B80","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/jat\/bkac007","article-title":"An enhanced LC-MS-MS technique for distinguishing Delta8- and Delta9-tetrahydrocannabinol isomers in blood and urine specimens","volume":"46","author":"Reber","year":"2022","journal-title":"J Anal Toxicol"},{"key":"2026052302060992000_bkag007-B81","volume-title":"Agriculture Improvement Act of 2018","author":"Congress","year":"2018"},{"key":"2026052302060992000_bkag007-B82","doi-asserted-by":"crossref","first-page":"103065","DOI":"10.1016\/j.drugpo.2020.103065","article-title":"Selectivity and sensitivity of urine fentanyl test strips to detect fentanyl analogues in illicit drugs","volume":"90","author":"Bergh","year":"2021","journal-title":"Int J Drug Policy"},{"key":"2026052302060992000_bkag007-B83","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.clinbiochem.2023.01.001","article-title":"Detection of 58 fentanyl analogs using ARK fentanyl II and Immunalysis fentanyl immunoassays","volume":"113","author":"Williams","year":"2023","journal-title":"Clin Biochem"},{"key":"2026052302060992000_bkag007-B84","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/jat\/bkaa181","article-title":"Detection of 30 fentanyl analogs by commercial immunoassay kits","volume":"45","author":"Wharton","year":"2021","journal-title":"J Anal Toxicol"},{"key":"2026052302060992000_bkag007-B85","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3390\/neurolint14030053","article-title":"Novel designer benzodiazepines: comprehensive review of evolving clinical and adverse effects","volume":"14","author":"Edinoff","year":"2022","journal-title":"Neurol Int"},{"key":"2026052302060992000_bkag007-B86","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/jat\/bkab108","article-title":"Urine drug screening in the era of designer benzodiazepines: comparison of three immunoassay platforms, LC-QTOF-MS and LC-MS-MS","volume":"46","author":"Puzyrenko","year":"2022","journal-title":"J Anal Toxicol"},{"key":"2026052302060992000_bkag007-B87","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1056\/NEJMc2313463","article-title":"SGLT2 inhibitors and false positive toxicology tests","volume":"390","author":"Schwartz","year":"2024","journal-title":"N Engl J Med"},{"key":"2026052302060992000_bkag007-B88","doi-asserted-by":"crossref","first-page":"e738","DOI":"10.1016\/j.amjmed.2019.04.029","article-title":"A challenge is brewing: false-positive urine alcohol in an elderly diabetic male","volume":"132","author":"Borgan","year":"2019","journal-title":"Am J Med"},{"key":"2026052302060992000_bkag007-B89","first-page":"276","article-title":"A positive urine alcohol with negative urine ethyl-glucuronide","volume":"49","author":"Foley","year":"2018","journal-title":"Lab Med"},{"key":"2026052302060992000_bkag007-B90","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.forsciint.2014.02.007","article-title":"Inhalation but not transdermal resorption of hand sanitizer ethanol causes positive ethyl glucuronide findings in urine","volume":"237","author":"Arndt","year":"2014","journal-title":"Forensic Sci Int"},{"key":"2026052302060992000_bkag007-B91","first-page":"E583","article-title":"Clinical benefits of direct-to-definitive testing for monitoring compliance in pain management","volume":"21","author":"Gencheva","year":"2018","journal-title":"Pain Physician"},{"key":"2026052302060992000_bkag007-B92","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1373\/jalm.2017.024166","article-title":"Lowering the bar for mass spectrometry: a comparison between immunoassay and rapid time-of-flight for presumptive screening of drugs in urine","volume":"2","author":"Rasmussen","year":"2018","journal-title":"J Appl Lab Med"}],"container-title":["Journal of Analytical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jat\/advance-article-pdf\/doi\/10.1093\/jat\/bkag007\/66754538\/bkag007.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jat\/article-pdf\/50\/4\/bkag007\/66754538\/bkag007.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jat\/article-pdf\/50\/4\/bkag007\/66754538\/bkag007.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T06:06:28Z","timestamp":1779516388000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jat\/article\/doi\/10.1093\/jat\/bkag007\/8460769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":92,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,5,23]]}},"URL":"https:\/\/doi.org\/10.1093\/jat\/bkag007","relation":{},"ISSN":["0146-4760","1945-2403"],"issn-type":[{"value":"0146-4760","type":"print"},{"value":"1945-2403","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,2,4]]},"article-number":"bkag007"}}